Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Mar 7, 2022
Document Date
Feb 23, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
CLARK ELIANA